Funding
← Back to your selection

Point72

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Jan 1, 2026
Rounds participated in
3
Confirmed lead rounds
0
2 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$3.3B
3 disclosed · full round size, not this investor’s share

By stage

Series B2
Series C+1

By primary sector

AI1
Biotech1
Climate tech1

By country

United States2
United Kingdom1

Rounds

3 in this selection
Valar Atomics

Valar Atomics develops modular nuclear reactors and energy campuses for industrial heat and electricity.

$1BSeries B
Participant
Nscale

Provides vertically integrated AI infrastructure for enterprise AI training, fine-tuning, and inference

$2BSeries C
Role not disclosed
Mirador Therapeutics

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

$250MSeries B
Role not disclosed